Cargando…
MUC1 stimulates EGFR expression and function in endometrial cancer
The current standard of care for endometrial cancer patients involves hysterectomy with adjuvant radiation and chemotherapy, with no effective treatment for advanced and metastatic disease. MUC1 is a large, heavily glycosylated transmembrane protein that lubricates and protects cell surfaces and inc...
Autores principales: | Engel, Brian J., Bowser, Jessica L., Broaddus, Russell R., Carson, Daniel D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078052/ https://www.ncbi.nlm.nih.gov/pubmed/27092881 http://dx.doi.org/10.18632/oncotarget.8743 |
Ejemplares similares
-
Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling
por: Williams, Erin, et al.
Publicado: (2017) -
Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB
por: Morgado, Micaela, et al.
Publicado: (2016) -
Differential expression of MUC genes in endometrial and cervical tissues and tumors
por: Hebbar, Vidya, et al.
Publicado: (2005) -
Highly glycosylated MUC1 mediates high affinity L-selectin binding at the human endometrial surface
por: Francis, Lewis W., et al.
Publicado: (2021) -
Mechanisms of mutant β-catenin in endometrial cancer progression
por: Parrish, Molly L., et al.
Publicado: (2022)